382 related articles for article (PubMed ID: 20142748)
1. Improved detection of hepatic metastases from pancreatic cancer using periodically rotated overlapping parallel lines with enhanced reconstruction (PROPELLER) technique after SPIO administration.
Hirokawa Y; Isoda H; Okada T; Arizono S; Shimada K; Yamamoto A; Shibata T; Togashi K
Invest Radiol; 2010 Mar; 45(3):158-64. PubMed ID: 20142748
[TBL] [Abstract][Full Text] [Related]
2. Hepatic lesions: improved image quality and detection with the periodically rotated overlapping parallel lines with enhanced reconstruction technique--evaluation of SPIO-enhanced T2-weighted MR images.
Hirokawa Y; Isoda H; Maetani YS; Arizono S; Shimada K; Okada T; Shibata T; Togashi K
Radiology; 2009 May; 251(2):388-97. PubMed ID: 19401572
[TBL] [Abstract][Full Text] [Related]
3. Hepatic metastases: diffusion-weighted sensitivity-encoding versus SPIO-enhanced MR imaging.
Nasu K; Kuroki Y; Nawano S; Kuroki S; Tsukamoto T; Yamamoto S; Motoori K; Ueda T
Radiology; 2006 Apr; 239(1):122-30. PubMed ID: 16493012
[TBL] [Abstract][Full Text] [Related]
4. [Use of SPIO-enhanced T1- and T2-weighted images for the differentiation of liver lesions: an ROC analysis].
Stroszczynski C; Gaffke G; Gretschel S; Rambow A; Jost D; Schlecht I; Schneider U; Schicke B; Hohenberger P; Gebauer B; Felix R
Rofo; 2003 Oct; 175(10):1368-75. PubMed ID: 14556106
[TBL] [Abstract][Full Text] [Related]
5. Hepatic metastases: detection with multi-detector row CT, SPIO-enhanced MR imaging, and both techniques combined.
Onishi H; Murakami T; Kim T; Hori M; Iannaccone R; Kuwabara M; Abe H; Nakata S; Osuga K; Tomoda K; Passariello R; Nakamura H
Radiology; 2006 Apr; 239(1):131-8. PubMed ID: 16484347
[TBL] [Abstract][Full Text] [Related]
6. Hepatic lesion detection and characterization: value of nonenhanced MR imaging, superparamagnetic iron oxide-enhanced MR imaging, and spiral CT-ROC analysis.
Reimer P; Jähnke N; Fiebich M; Schima W; Deckers F; Marx C; Holzknecht N; Saini S
Radiology; 2000 Oct; 217(1):152-8. PubMed ID: 11012438
[TBL] [Abstract][Full Text] [Related]
7. Comparison of ferucarbotran-enhanced fluid-attenuated inversion-recovery echo-planar, T2-weighted turbo spin-echo, T2*-weighted gradient-echo, and diffusion-weighted echo-planar imaging for detection of malignant liver lesions.
Fukukura Y; Kamiyama T; Takumi K; Shindo T; Higashi R; Nakajo M
J Magn Reson Imaging; 2010 Mar; 31(3):607-16. PubMed ID: 20187203
[TBL] [Abstract][Full Text] [Related]
8. Hepatic lesion detection: comparison of MR imaging after the administration of superparamagnetic iron oxide with dual-phase CT by using alternative-free response receiver operating characteristic analysis.
Ward J; Naik KS; Guthrie JA; Wilson D; Robinson PJ
Radiology; 1999 Feb; 210(2):459-66. PubMed ID: 10207430
[TBL] [Abstract][Full Text] [Related]
9. MR imaging with i.v. superparamagnetic iron oxide: efficacy in the detection of focal hepatic lesions.
Winter TC; Freeny PC; Nghiem HV; Mack LA; Patten RM; Thomas CR; Elliott S
AJR Am J Roentgenol; 1993 Dec; 161(6):1191-8. PubMed ID: 8249724
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of super paramagnetic iron oxide-enhanced diffusion-weighted PROPELLER T2-fast spin echo magnetic resonance imaging: Preliminary experience.
Kiryu S; Watanabe M; Kabasawa H; Akahane M; Aoki S; Ohtomo K
J Comput Assist Tomogr; 2006; 30(2):197-200. PubMed ID: 16628031
[TBL] [Abstract][Full Text] [Related]
11. [Hepatic and hepatocarcinoma magnetic resonance: comparison of the results obtained with paramagnetic (gadolinium) and superparamagnetic (iron oxide particles) contrast media].
Castoldi MC; Fauda V; Scaramuzza D; Vergnaghi D
Radiol Med; 2000 Sep; 100(3):160-7. PubMed ID: 11148882
[TBL] [Abstract][Full Text] [Related]
12. Hepatocellular lesions with increased iron uptake on superparamagnetic iron oxide-enhanced magnetic resonance imaging in cirrhosis or chronic hepatitis: comparison of four magnetic resonance sequences for lesion conspicuity.
Tanabe M; Ito K; Shimizu A; Fujita T; Onoda H; Yamatogi S; Washida Y; Matsunaga N
Magn Reson Imaging; 2009 Jul; 27(6):801-6. PubMed ID: 19144487
[TBL] [Abstract][Full Text] [Related]
13. Hepatocellular carcinoma: detection with gadolinium- and ferumoxides-enhanced MR imaging of the liver.
Pauleit D; Textor J; Bachmann R; Conrad R; Flacke S; Layer G; Kreft B; Schild H
Radiology; 2002 Jan; 222(1):73-80. PubMed ID: 11756708
[TBL] [Abstract][Full Text] [Related]
14. Three-dimensional dynamic liver MR imaging using sensitivity encoding for detection of hepatocellular carcinomas: comparison with superparamagnetic iron oxide-enhanced mr imaging.
Kim YK; Kim CS; Kwak HS; Lee JM
J Magn Reson Imaging; 2004 Nov; 20(5):826-37. PubMed ID: 15503325
[TBL] [Abstract][Full Text] [Related]
15. Colorectal hepatic metastases: detection with SPIO-enhanced breath-hold MR imaging--comparison of optimized sequences.
Ward J; Guthrie JA; Wilson D; Arnold P; Lodge JP; Toogood GJ; Wyatt JI; Robinson PJ
Radiology; 2003 Sep; 228(3):709-18. PubMed ID: 12888620
[TBL] [Abstract][Full Text] [Related]
16. Detection of hepatic metastases by superparamagnetic iron oxide-enhanced MR imaging: prospective comparison between 1.5-T and 3.0-T images in the same patients.
Sofue K; Tsurusaki M; Miyake M; Sakurada A; Arai Y; Sugimura K
Eur Radiol; 2010 Sep; 20(9):2265-73. PubMed ID: 20428875
[TBL] [Abstract][Full Text] [Related]
17. Detection of liver metastases: gadobenate dimeglumine-enhanced three-dimensional dynamic phases and one-hour delayed phase MR imaging versus superparamagnetic iron oxide-enhanced MR imaging.
Kim YK; Lee JM; Kim CS; Chung GH; Kim CY; Kim IH
Eur Radiol; 2005 Feb; 15(2):220-8. PubMed ID: 15624108
[TBL] [Abstract][Full Text] [Related]
18. Malignant hepatic tumor detection with ferumoxide-enhanced magnetic resonance imaging: is chemical-shift-selective fat suppression necessary for fast spin-echo sequence?
Goshima S; Kanematsu M; Matsuo M; Kondo H; Kako N; Yokoyama R; Hoshi H; Moriyama N
J Magn Reson Imaging; 2004 Jul; 20(1):75-82. PubMed ID: 15221811
[TBL] [Abstract][Full Text] [Related]
19. Detection and characterization of focal hepatic lesions: mangafodipir vs. superparamagnetic iron oxide-enhanced magnetic resonance imaging.
Kim MJ; Kim JH; Lim JS; Oh YT; Chung JJ; Choi JS; Lee WJ; Kim KW
J Magn Reson Imaging; 2004 Oct; 20(4):612-21. PubMed ID: 15390224
[TBL] [Abstract][Full Text] [Related]
20. Small malignant hepatic tumor detection in gadolinium- and ferucarbotran-enhanced magnetic resonance imaging: does combining ferucarbotran-enhanced T2*-weighted gradient echo and T2-weighted turbo spin echo images have additive efficacy?
Kim YK; Lee YH; Kwak HS; Kim CS; Han YM
Korean J Radiol; 2008; 9(6):510-9. PubMed ID: 19039267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]